BioXcel (BTAI) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -106.6 | -157.2 | -165.4 | -44.2 | -52.6 | -59.5 | ||
| Changes by years, y/y, % | +30% | +47% | +5% | -73% | +19% | -8.5% | |||
BioXcel. EBITDA US GAAP, bln rub
BioXcel. EBITDA US GAAP, changes, %
BioXcel. EBITDA US GAAP, sum by quarters, bln rub
BioXcel (BTAI) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -3.19 | -14.9 | -26.5 | -8.08 | -8.44 | -59.5 | |
| Changes by years, y/y, % | -86% | +229% | +170% | +20% | +165% | |||
| Changes by quarters, q/q, % | -53% | +368% | +78% | -69% | +4% | |||